Table 3.
Patient sex/No. | Total hip Z score | Total spine Z score | Drug treatment protocola | Cumulative prednisolone equivalent dose (mg) | Cumulative ribavirin dose (mg) |
---|---|---|---|---|---|
M/1 | −1.60 | −2.59 | II | 625 | 19,200 |
M/2 | −2.06 | −2.37 | I | 770 | 32,400 |
M/3 | −2.09 | −1.77 | IV | 5120 | 36,000 |
M/4 | −2.18 | −1.33 | III | 2545 | 28,800 |
M/5 | −2.19 | −0.76 | IV | 8915 | 14,400 |
M/6 | −2.85 | −2.12 | I | 330 | 24,000 |
F/1 | −2.05 | −1.77 | IV | 4410 | 3600 |
F/2 | −2.06 | −1.66 | III | 1885 | 50,400 |
F/3 | −2.20 | −1.86 | IV | 3010 | 4800 |
F/4 | −2.43 | −3.20 | II | 3335 | 12,000 |
I: Oral ribavirin as a loading dose of 2.4 g stat followed by 1.2 g three times daily and prednisolone 0.5–1 mg/kg body weight per day. II: Intravenous ribavirin (400 mg every 8 h) combined with hydrocortisone (100 mg every 8 h). III: Pulses of high-dose methylprednisolone (0.5 g IVI for three consecutive days) added on initial combination therapy. IV: Further pulse of methylprednisolone, up to a total of 3 g.